Pharmaceutical Technology
JULY 15, 2022
Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.
STAT News
APRIL 21, 2023
WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate, a pair of key senators have significantly changed a proposal to cap insulin costs. The new legislation by Senate Diabetes Caucus co-chairs Sens. Jeanne Shaheen (D-N.H.) Jeanne Shaheen (D-N.H.) Read the rest…
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT News
AUGUST 7, 2022
WASHINGTON — Democrats’ high hopes to lower insulin costs for patients with insurance got downsized on Sunday, and now only Medicare patients will see relief at the pharmacy counter. Back in November, the party had grand ambitions of capping insulin costs at $35 per month for all patients with insurance.
XTalks
FEBRUARY 8, 2024
In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6 percent in the US, impacted by prior formulary losses as well as “erosion of the basal insulin market,” the company said in the statement. In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6
Pharmacy Checkers
MARCH 11, 2020
Founded in 2002, and launching its website in 2003, PharmacyChecker provides consumers with online pharmacy verification and comparative drug price information to help them make the best decisions for themselves and their families on how to afford prescription drugs. counterparts.
Pharmacy Checkers
FEBRUARY 21, 2020
Canadian pharmacies sell these American-made drugs at much lower cost, but that law prevents companies from buying those drugs and re-selling them here. pharmacies, but also sold in other countries, too. Those contracts are based on NDC numbers, unique codes tagged to the drug package. and exported can’t be sent back to the U.S.
XTalks
JANUARY 24, 2024
This disparity can be attributed to various factors, including the lack of government regulation on drug prices and the complex web of negotiations between drug manufacturers, insurers and pharmacy benefit managers. ” If authorized, Sanders said these would be the first subpoenas issued by the HELP Committee since 1981.
Expert insights. Personalized for you.
328 
Let's personalize your content